Vitamin Shoppe now CL-Buy at Goldman

|About: Vitamin Shoppe, Inc. (VSI)|By:, SA News Editor

Vitamin Shoppe (VSI) lands on the coveted Conviction Buy list at Goldman.

Analyst Stephen Tanal expects "sharp acceleration in same-store sales growth in Q4 [and says] artificially depressed 2013 EBIT margins are set to inflect."

Price target hiked to $65 from $59.

In Q3, comps printed at +2.6%, marking the 32nd consecutive quarter of positive SSS growth.